Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism?

被引：19
作者：
Skeith, Leslie [1 ]
Le Gal, Gregoire [2 ]
Rodger, Marc A. [3 ]
机构：
[1] Univ Calgary, Dept Med, Div Hematol & Hematol Malignancies, Calgary, AB, Canada
[2] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada
[3] McGill Univ, Dept Med, Montreal, PQ, Canada
来源：
THROMBOSIS RESEARCH | 2021年 / 202卷
关键词：
Venous thromboembolism; Contraceptives; oral; Estrogen replacement therapy; FACTOR-V-LEIDEN; RECURRENCE RISK; WOMEN; THROMBOSIS; YOUNG; THROMBOPHILIA; METAANALYSIS; COAGULATION; KNEE; VTE;
D O I：
10.1016/j.thromres.2021.03.012
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Exogenous hormone therapies, such as combined oral contraceptives (COC) and hormone replacement therapy (HRT), cause blood hypercoagulability and are a risk factor for venous thromboembolism (VTE). There is controversy on how strong this "provoking" risk factor is, and how other risk factors may synergise VTE risk. We aim to review the latest literature on the risk of initial and recurrent VTE with COC and HRT use to provide guidance for decision-making about duration of anticoagulation, and guide future research efforts.
引用
收藏
页码：134 / 138
页数：5
相关论文
共 51 条
[41]   Self-reported family history in estimating the risk of hormone, surgery and cast related VTE in women [J].
Sonnevi, Kristina ;
Bergendal, Annica ;
Adami, Johanna ;
Larfars, Gerd ;
Kieler, Helle .
THROMBOSIS RESEARCH, 2013, 132 (02) :164-169
[42]   Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study [J].
Sweetland, S. ;
Beral, V. ;
Balkwill, A. ;
Liu, B. ;
Benson, V. S. ;
Canonico, M. ;
Green, J. ;
Reeves, G. K. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (11) :2277-2286
[43]  
Vaillant-Roussel Helene, 2011, Contraception, V84, pe23, DOI 10.1016/j.contraception.2011.06.008
[44]   Below-knee cast immobilization and the risk of venous thrombosis: results from a large population-based case-control study [J].
van Adrichem, R. A. ;
Debeij, J. ;
Nelissen, R. G. H. H. ;
Schipper, I. B. ;
Rosendaal, F. R. ;
Cannegieter, S. C. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (09) :1461-1469
[45]  
Van Vliet HAAM, 2008, J THROMB HAEMOST, V6, P346, DOI 10.1111/j.1538-7836.2008.02863.x
[46]   Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis [J].
van Vlijmen, E. F. W. ;
Wiewel-Verschueren, S. ;
Monster, T. B. M. ;
Meijer, K. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (07) :1393-1403
[47]   Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects - Results from a retrospective family cohort study [J].
van Vlijmen, Elizabeth F. W. ;
Brouwer, Jan-Leendert P. ;
Veeger, Nic J. G. M. ;
Eskes, Tom K. A. B. ;
de Graeff, Pieter A. ;
van der Meer, Jan .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (03) :282-289
[48]   Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception [J].
van Vlijmen, Elizabeth F. W. ;
Veeger, Nic J. G. M. ;
Middeldorp, Saskia ;
Hamulyak, Karly ;
Prins, Martin H. ;
Buller, Harry R. ;
Meijer, Karina .
BLOOD, 2011, 118 (08) :2055-2061
[49]  
Vandenbroucke J.P., 1995, LANCET, V50, P531
[50]   Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases [J].
Vinogradova, Yana ;
Coupland, Carol ;
Hippisley-Cox, Julia .
BMJ-BRITISH MEDICAL JOURNAL, 2019, 364
123456